Posts By Alex
442Wire StoriesTakeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
OSAKA, Japan & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Takeda (TSE:4502/NYSE: TAK) today announced that the Phase 3 ADMIRE-CD II study, assessing the efficacy and safety...
- 481Wire Stories
PPG divests Traffic Solutions operations in Australia and New Zealand
PITTSBURGH–(BUSINESS WIRE)–PPG (NYSE:PPG) today announced that it has divested all Traffic Solutions operations in Australia and New Zealand to Geveko Markings, a...
- 429Wire Stories
Asia Pacific IT, Business Services Spending Down in Q3, ISG Indexâ„¢ Shows
Managed services ACV fell 13%, while XaaS spending was down 9% in third quarter SYDNEY–(BUSINESS WIRE)–$III #AsaService–After a strong second quarter, demand...
- 527Wire Stories
Triton Digital Releases the Australian Podcast Ranker for September 2023
SYDNEY–(BUSINESS WIRE)–Triton Digital®, the global technology and services leader to the digital audio, podcast, and broadcast radio industries, announced today the release...
- 396Wire Stories
SSR Mining Announces the Sale of Its Sunrise Lake Exploration Property
DENVER–(BUSINESS WIRE)–SSR Mining Inc. (NASDAQ/TSX: SSRM, ASX: SSR) (“SSR Mining†or the “Companyâ€) announced today that it has entered into a definitive...
- 387Wire Stories
Oneview Healthcare and Baxter Announce Connected Care Collaboration During Meeting with Enterprise Ireland
CHICAGO–(BUSINESS WIRE)–Oneview Healthcare (Oneview), a leading provider of patient experience solutions, and Baxter International Inc. (Baxter), a global medtech leader, are pleased...
- 375Wire Stories
ClickUp Doubles Down on Investment in APAC with Localised Data Hosting and Regional Hires
ClickUp expands presence in-region to grow impact and better support customers SYDNEY–(BUSINESS WIRE)–ClickUp, the productivity platform that brings work together in one...
- 443Wire Stories
Outstaffer Raises $1.5 Million From Leading Australian Venture Capital Investors
This strategic round of funding enabled the self-funded startup to accelerate growth and launch its SaaS Global Workforce Platform. MELBOURNE, Australia–(BUSINESS WIRE)–#AustraliaVCs–Outstaffer,...
- 420Wire Stories
BeiGene Announces Late-Breaking Data at ESMO Showing Tislelizumab plus Chemotherapy Significantly Improved Overall Survival at Final Analysis in First-Line Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
First-line tislelizumab plus chemotherapy demonstrated a median overall survival of 15.0 months versus 12.9 months for placebo plus chemotherapy in the intent-to-treat...
- 389Wire Stories
BeiGene Announces the Phase 3 RATIONALE 315 Trial Met Primary Endpoints of Major Pathological Response Rate and Event-Free Survival for Tislelizumab Plus Chemotherapy in Patients with Resectable Non-Small Cell Lung Cancer (NSCLC)
Late-breaking ESMO data show 56.2% of patients with resectable NSCLC who received tislelizumab plus chemotherapy before surgery achieved major pathological response, versus...
